Strategic Collaborations and Venture Capital Investment Bolster U.S. Cell and Gene Therapy Clinical Trials Market Expansion
The U.S. cell and gene therapy clinical trials market has entered a phase of accelerated expansion, reflecting both national leadership in biotechnology and global interconnectivity in clinical research. Valued at USD 5.36 billion in 2024, the market is projected to expand at a CAGR of 15.3% from 2025 to 2034, underscoring the rapid integration of innovative therapeutic platforms across...
0 Comments 0 Shares 669 Views 0 Reviews